Skip to content

Clinical trials

Phase 2 Basal Cell Carcinoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Basal Cell Carcinoma Phase: Phase 2 Country / region: United States Clear all

44 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20043
20071
20081
20092
20102
20111
20121
20132
20142
20152
20161
20173
20182
20191
20202
20213
20222
20231
20242
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Recruiting6
Terminated5
Active, not recruiting4
Unknown status2
Suspended1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)4
Genentech, Inc.3
UCSF Benioff Children's Hospital Oakland3
Hoffmann-La Roche2
Mayo Clinic2
Memorial Sloan Kettering Cancer Center2
Philogen S.p.A.2
Regeneron Pharmaceuticals2
Roswell Park Cancer Institute2
University of Arizona2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Basal Cell Carcinoma44
Basal Cell Nevus Syndrome7
Skin Neoplasms7
Carcinoma, Merkel Cell3
Keratosis, Actinic3
Carcinoma, Squamous Cell2
Carcinoma, Transitional Cell2
Colorectal Neoplasms2
Cutaneous Squamous Cell Carcinoma2
Neoplasms2

Trials

Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.